Can a menopause-mimicking drug fight fatty liver in endometriosis patients?

NCT ID NCT06523530

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study tests whether goserelin acetate, a drug that temporarily stops menstruation (like a short-term menopause), can reduce liver fat in women with endometriosis who also have fatty liver disease. Researchers will measure liver fat and stiffness using ultrasound in 62 women over 6 months. The goal is to see if this approach can improve liver health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Goserelin acetate (Zoladex), a drug that temporarily stops menstruation
What this could lead to
If it works, this could point toward a new way to treat fatty liver disease in women with endometriosis by using a temporary menopause-like state.
What could go wrong
This is a small, early-phase trial with only 62 participants. The drug causes temporary menopause, which may have side effects like hot flashes and bone thinning, and the liver benefit is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • 1st Department of Obstetrics and Gynecology, School of Medicine, Aristotle University of Thessaloniki

    Thessaloniki, 56403, Greece

  • 424 General Military Hospital

    Thessaloniki, Thessaloniki, 56429, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.